Indian markets consolidated in a narrow range during the truncated week, with Nifty ending marginally positive. The index remains below its recent high, awaiting a decisive catalyst. Traders are advised to be cautious and focus on stock-specific opportunities with risk management.
Pharma, Auto, and IT: Pankaj Pandey shares sectoral insights amid global challenges
Pankaj Pandey shares insights on Indian sectors facing US tariffs. He sees limited impact on pharma growth but potential benefits for Jubilant Pharma and Piramal